Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
35 hedge funds and large institutions have $125K invested in Ampio Pharmaceuticals Inc. in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
45% more capital invested
Capital invested by funds: $86.3K → $125K (+$38.5K)
9% more funds holding
Funds holding: 32 → 35 (+3)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$56.9K |
| 2 |
Renaissance Technologies
New York
|
+$4.83K |
| 3 |
VF
Virtu Financial
New York
|
+$4.21K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$3.9K |
| 5 |
Goldman Sachs
New York
|
+$3.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.7K |
| 2 |
Millennium Management
New York
|
-$6.39K |
| 3 |
CC
Courier Capital
Buffalo,
New York
|
-$4.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$1.11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$753 |
AMPE Hedge Fund Activity: Q1 2023 in Review
35 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2023, worth a combined $125K — up 45% from $86.3K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AMPE positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 8 trimmed.
The largest buyer was HRT Financial, adding an estimated $56.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $18.7K sold.
- 35 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2023, up from 32 in Q4 2022.
- Funds reported $125K of Ampio Pharmaceuticals Inc. stock for Q1 2023, up 45% quarter-over-quarter.
- 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2023 and 2 closed out, a net change of +5 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2023 was HRT Financial, an estimated $56.9K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2023 was Susquehanna International Group, an estimated $18.7K sold.
Based on aggregated 13F filings for Q1 2023.